SCHEMBL29952115

SCHEMBL29952115

CCCCOc1ccccc1B(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 2/20 0.58
CYP1A2 P05177 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
ENPP2 Q13822 2/20 0.53
LIPG Q9Y5X9 1/20 0.50
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
NR1I2 O75469 1/20 0.46
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADRA2A P08913 1/20 0.46
MAPT P10636 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
LTA4H P09960 2/20 0.44
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660589 1.00 LIPE (0.58) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL29953651 0.94 LIPE (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL29957484 0.93 LIPG (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL29953962 0.93 LIPG (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL14988714 0.93 LIPG (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL7632353 0.93 LIPG (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL29954947 0.93 LIPG (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL29957829 0.93 LIPG (0.56) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL1684575 0.90 LIPE (0.59) LIPECYP1A2CYP2C9CYP2C19ENPP2
SCHEMBL29952366 0.90 LIPE (0.59) LIPECYP1A2CYP2C9CYP2C19ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096932-A1 METHODS FOR REDUCING LIPASE ACTIVITY USING STRESS REGENERON PHARMACEUTICALS, INC. (US) 2025-05-08 WO disclosed
EP-4518839-A2 METHODS FOR REDUCING LIPASE ACTIVITY Regeneron Pharmaceuticals, Inc. (US) 2025-03-12 EP disclosed
CN-119497609-A Method for reducing lipase activity 瑞泽恩制药公司 2025-02-21 CN disclosed
WO-2023215750-A2 METHODS FOR REDUCING LIPASE ACTIVITY REGENERON PHARMACEUTICALS, INC. (US) 2023-11-09 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed